Recently, other antibodies were used to assess the counts of MVD in cervical cancer [30, 31], such as CD31 (also known as platelet endothelial cell adhesion molecule), CD34 and CD105 (also known as Endoglin). This evidence concerns the gene PECAM1 and cervical cancer.